Drug Type Small molecule drug |
Synonyms Alovudine (USAN/INN), FLT, FddThd + [3] |
Target |
Mechanism POLG inhibitors(DNA polymerase gamma, catalytic subunit inhibitors), RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC10H13FN2O4 |
InChIKeyUXCAQJAQSWSNPQ-XLPZGREQSA-N |
CAS Registry25526-93-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | CA | 07 Dec 2017 | |
Acute Myeloid Leukemia | Preclinical | SE | 07 Dec 2017 | |
HIV Infections | Preclinical | SE | - | - |
HIV Infections | Preclinical | - | - | |
HIV Infections | Preclinical | - | - | |
HIV Infections | Preclinical | FR | - | - |
HIV Infections | Preclinical | US | - | - |
Not Applicable | - | (Pelvic cancer patients) | tcbnusinci(vqxcjkreiv) = dllcqxnjfk ofuxaiznes (pssnsculfx, 434) | - | 01 Nov 2018 | ||
Not Applicable | - | pwtmjbbicr(fmojfokxcw) = mzcynknsuw ugswpvtbev (njzxvppzwk, 0.1) View more | - | 15 May 2015 | |||
Not Applicable | - | 15 | rtrbirhluo(czgnycflzn) = hxqlgzhozx oxvqergyoh (eqfxhkvdnw ) | - | 01 Jan 2002 |